FRBT earnings analysis
What we found in FRBT's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The provided extract is limited to Part II disclosures and does not contain the income statement, balance sheet, cash-flow statement, segment revenue, or comparative-period data; therefore revenue, margins, EPS, operating cash flow, free cash flow, and period-over-period trends cannot be verified from the filing text supplied. The filing indicates a $7.3 billion deposit base, an 83.5% loan-to-deposit ratio, and a healthcare finance concentration of approximately 30% of loans. Key forward-looking concerns are deposit pricing and liquidity volatility, healthcare reimbursement and credit risk, inflation, and evolving capital requirements.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Strong deposit funding base
- Deposits were $7.3 billion as of June 30, 2026, with a loan-to-deposit ratio of 83.5%, indicating substantial deposit funding for the loan portfolio.
- Diversified lending strategies
- Healthcare finance represented approximately 30% of the loan portfolio as of June 30, 2026, while no other lending strategy represented more than 20%, providing diversification outside the largest concentration.
- Controls remained effective
- Management concluded that disclosure controls and procedures were effective as of June 30, 2026, and reported no material changes to internal control over financial reporting during the quarter.
- Capital framework remains available
- The company and the Bank elected the CBLR framework and reported that, effective July 1, 2026, qualifying institutions must maintain a leverage ratio greater than 8% to be considered well capitalized.
- Limited non-interest-rate exposure
- The company reported no material exposure to foreign currency exchange, commodity price, or equity price risk; interest-rate volatility and inflation were identified as the primary market risks.
- Lending leadership retained
- The August 13, 2026 employment agreement for Kenneth Elias provides for a three-year initial term, a $500,000 annual base salary, and a target annual bonus of at least 100% of base salary.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Healthcare concentration risk
- Healthcare finance represented approximately 30% of the loan portfolio as of June 30, 2026, with exposure concentrated in skilled nursing and seniors housing; changes in Medicare or Medicaid reimbursement rates could increase defaults, ACL requirements, and charge-offs.
- Uninsured and rate-sensitive deposits
- The company estimated that $1.0 billion of its $7.3 billion deposit base exceeded FDIC insurance limits as of June 30, 2026. Management warns that digital deposits can experience significant outflows within short periods due to competition, rate changes, or loss of confidence.
- Capital rule transition risk
- The CBLR framework changes effective July 1, 2026 require a leverage ratio greater than 8% for well-capitalized status, with a four-quarter grace period only if the ratio remains above 7%; failure to meet capital standards could restrict distributions and other activities.
What they said about what is next.
The provided filing extract does not include quantitative revenue, earnings, margin, or cash-flow guidance. Management states that deposit-pricing competition and growth-related expenses are expected to continue, but provides no numeric outlook.
The filing reads about the same as the one before it.
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing FRBT makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever